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CASE REPORT
L-2-Hydroxyglutaric Aciduria is a Diagnostic Indicator of Leukodystrophy: A 
Case Report
Abstract
L-2-Hydroxyglutaric aciduria is a rare autosomal recessive inherited 
neurometabolic disorder.It is characterized by slow progressive neurological 
dysfunction with cerebellar ataxia, pyramidal and extrapyramidal signs, 
intellectual decline, and seizures. Herein, we report a case of a 7-year-old boy 
from Tehran whose symptoms and signs indicated leukoencephalopathy with 
macrocephaly and motor delay.
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Introduction
L-2-Hydroxyglutaric aciduria is a rare autosomal recessive inherited neurometabolic 
disorder. Since its first description by Duran in 1980, L-2-hydroxyglutaric aciduria 
has been reported in less than 100 patients (1). It is characterized by slow progressive 
neurological dysfunction with cerebellar ataxia, pyramidal and extrapyramidal 
signs, intellectual decline and seizures (2). White matter changes observed on 
magnetic resonance imaging (MRI) were highly suggestive of this disorder (1, 2). 
The condition is diagnosed by screening urine, blood, and/or cerebrospinal fluid for 
L-2-hydroxyglutaric acid (2, 3). Herein, we report a case of a 7-year-old boy whose 
symptoms and signs indicated leukoencephalopathy with macrocephaly and motor 
delay. The patient was diagnosed with L-2-hydroxyglutaric aciduria on the basis of 
urinalysis using gas chromatography and mass spectrometry (GC/MS). 
 
Case Report
The patient was a 7-year-old boy from Tehran who had an unremarkable perinatal 
and postnatal history. The circumference of his head at birth was 35 cm. His parents 
were healthy and first cousins. The growth and development of the patient was 
almost normal during the first 5 years of his life. Thereafter, the parents noticed the 
child’s diminished ability to stand up from a seated position. The child also showed 
a disturbed ability to paint. After a few months, he could not walk and run normally 
and fell down frequently. He had no seizures or abnormal movements such as tremor 
or dystonia. At presentation, the circumference of his head was 57 cm. He showed 
ataxic gait and a tendency to bend forward. He developed tremors during writing 
and painting. Neurologic examination revealed hyperreflexia in the upper and lower 
limbs, mild spasticity, and decreased muscle force. Although he showed obvious 
deterioration of motor function, his cognitive and linguistic skills were acceptable, 
and he had normal visual function. 
His routine laboratory test findings were unremarkable, and the results of 
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electrophysiological study (electromyography [EMG]/
nerve conduction velocity [NCV] test) were normal. MRI 
of the brain revealed diffuse white matter changes that 
indicated leukodystrophy (Figure 1). Routine metabolic 
study revealed no remarkable findings; however, 
urinalysis for organic acids by using GC/MS revealed 
very high levels of L-2-hydroxyglutaric acid, indicating 
deficiency of 2-hydroxyglutarate dehydrogenase. On 
the basis of these findings, he was diagnosed with L-2-
hydroxyglutaric aciduria.
 
Discussion
L-2-Hydroxyglutaric aciduria is a rare autosomal 
recessive inherited neurometabolic disorder (1). It is 
caused by mutations in a gene present on chromosome 
14q22.1 that encodes for L-2-hydroxyglutarate 
dehydrogenase (1, 2). This flavin adenine dinucleotide 
(FAD)-linked mitochondrial enzyme catalyzes the 
irreversible conversion of L-2-hydroxyglutarate to alpha-
ketoglutarate. In patients with L-2-hydroxyglutaric 
aciduria, L-2-hydroxyglutaric acid accumulates and 
is toxic for brain tissue. Accumulation of this acid 
and its subsequent effects lead to the development of 
leukoencephalopathy and increases the susceptibility 
to develop brain tumors (2, 3). L-2-hydroxyglutaric 
aciduria is commonly diagnosed in infancy and 
childhood (4). It is characterized by slow progressive 
neurological dysfunction, gait disturbance, ataxia, 
seizures, macrocephaly, and abnormal findings on MRI 
(2, 3, 5). In fact, macrocephaly, cerebellar signs, and 
MRI abnormalities that suggesting leukodystrophy, 
are diagnostic clues. Urinalysis for organic acids is 
necessary because organic aciduria is a probable cause 
of leukodystrophy (6). Recently, the gene responsible 
for this disorder has been mapped to chromosome 
14q22.1 (7, 8). We suggest that urinalysis using GC/MS 
should be performed in patients with macrocephaly and 
leukoencephalopathy (8).
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Fig 1. Axial T2-Weighted Magnetic Resonance Imaging 
(MRI) Scan of the Patient Showing Subcortical and Deep 
White Matter Changes
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